微创仅腹部食管切除术与微创Ivor Lewis食管切除术的安全性比较
单中心回顾性队列研究比较微创仅腹部食管切除术(MIAE)与微创Ivor Lewis食管切除术(MIILE)治疗胃食管腺癌或狭窄的安全性,纳入17例MIAE与32例MIILE患者。MIAE组淋巴结清扫中位数更少、手术时间中位数更短,术前合并症评分与计算的手术风险更高,但两组在估计失血量、住院时间、肺部或心脏并发症及90天生存方面无差异。
要点
- MIAE组淋巴结清扫中位数更少、手术时间中位数更短(p<0.001)。
- MIAE组Charlson合并症指数与ACS NSQIP手术风险值显著更高(p<0.05)。
- 两组估计失血量、住院时间、心肺并发症及90天生存无显著差异。
核心结论
- 在特定患者人群中,微创仅腹部入路的安全性可与微创Ivor Lewis入路相比,且手术时间中位数更短。
- MIAE患者术前合并症更多、计算围术期并发症风险更高,但术后结局相似,提示MIAE或可用于不适合MIILE的胃食管腺癌或狭窄患者。
研究设计与样本
- 单中心回顾性队列研究,纳入胃食管腺癌或狭窄患者,比较MIAE与MIILE两种术式。
- 共纳入17例MIAE患者与32例MIILE患者。
- MIAE适用于狭窄小于五厘米或AJCC分期≤T2且无淋巴结肿大的癌症。
主要发现
- MIAE组淋巴结清扫中位数更少(p<0.001)。
- MIAE组手术时间中位数更短(p<0.001)。
- MIAE组Charlson合并症指数评分与ACS NSQIP手术风险值显著高于MIILE组(p<0.05)。
- 两组估计失血量中位数、住院时间、肺部或心脏并发症无差异。
- 两组90天生存无显著差异。
临床怎么用
- 对合并症较多、计算围术期风险较高且不适合MIILE的胃食管腺癌或狭窄患者,可考虑MIAE作为可选术式。
- 选择MIAE需权衡其淋巴结清扫数量中位数更少的因素。
局限性
- 单中心回顾性设计,样本量小(MIAE 17例、MIILE 32例),存在选择偏倚可能。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: We report mortality and post-operative complications from esophageal resection in the treatment of gastroesophageal adenocarcinoma or stricture, comparing a minimally invasive abdomen-only esophagectomy (MIAE) approach with a minimally invasive Ivor Lewis esophagectomy (MIILE) approach. METHODS: A single-center retrospective cohort study of patients with esophageal adenocarcinoma or stricture treated by either MIAE or MIILE was conducted. MIAE was offered for strictures less than five centimeters or cancers that were American Joint Committee on Cancer (AJCC) Stage ≤ T2 without lymphadenopathy. Patients treated with these surgical techniques were analyzed to assess pre-operative risk, intra and post-operative variables, adverse events, and overall survival. RESULTS: This study included 17 patients undergoing MIAE and 32 patients treated with MIILE. There were a fewer median number of lymph nodes resected (p < 0.001) and shorter operative duration (p < 0.001) for MIAE compared to MIILE. MIAE patients also had significantly higher Charlson Comorbidity Index scores and ACS National Surgical Quality Improvement Program (NSQIP) surgical risk values than MIILE patients (p < 0.05). There was no difference in median estimated blood loss, length of stay, pulmonary or cardiac complications between groups. There was no significant difference in 90-day survival. CONCLUSION: A minimally invasive abdomen-only approach in a specific patient population is comparable in safety to a minimally invasive Ivor Lewis approach, with associated shorter median operative duration. MIAE patients had significantly greater pre-operative comorbidities and higher calculated peri-operative risk of complication but demonstrated similar post-operative outcomes. This suggests that MIAE may be a suitable surgical approach for treating gastroesophageal adenocarcinoma or stricture in patients deemed unsuitable for MIILE.
引用
- Wang CP, Rogers MP, Bach G, et al. Safety comparison of minimally invasive abdomen-only esophagectomy versus minimally invasive Ivor Lewis esophagectomy: a retrospective cohort study. Surg Endosc. 2021. PMID: 33825009. doi:10.1007/s00464-021-08468-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。